Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Escalating Doses of IM-862 in Patients With Ovarian Cancer

NCT00003773 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00003773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Escalating Doses of IM-862 in Patients With Ovarian Cancer
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Completed
Start date
February 28, 1999
Completion date
August 31, 2001
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer